Publication: The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus.
dc.contributor.author | Sanabria-de la Torre, Raquel | |
dc.contributor.author | Garcia-Fontana, Cristina | |
dc.contributor.author | Gonzalez-Salvatierra, Sheila | |
dc.contributor.author | Andujar-Vera, Francisco | |
dc.contributor.author | Martinez-Heredia, Luis | |
dc.contributor.author | Garcia-Fontana, Beatriz | |
dc.contributor.author | Muñoz-Torres, Manuel | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | European Regional Development Fund (FEDER) | |
dc.contributor.funder | Junta de Andalucía | |
dc.contributor.funder | University of Granada | |
dc.date.accessioned | 2023-05-03T14:01:59Z | |
dc.date.available | 2023-05-03T14:01:59Z | |
dc.date.issued | 2022-06-21 | |
dc.description.abstract | Vascular complications are the leading cause of morbidity and mortality among patients with type 2 diabetes mellitus (T2DM). These vascular abnormalities result in a chronic hyperglycemic state, which influences many signaling molecular pathways that initially lead to increased oxidative stress, increased inflammation, and endothelial dysfunction, leading to both microvascular and macrovascular complications. Endothelial dysfunction represents the initial stage in both types of vascular complications; it represents "mandatory damage" in the development of microvascular complications and only "introductory damage" in the development of macrovascular complications. Increasing scientific evidence has revealed an important role of the Wnt pathway in the pathophysiology of the vascular wall. It is well known that the Wnt pathway is altered in patients with T2DM. This review aims to be an update of the current literature related to the Wnt pathway molecules that are altered in patients with T2DM, which may also be the cause of damage to the vasculature. Both microvascular complications (retinopathy, nephropathy, and neuropathy) and macrovascular complications (coronary artery disease, cerebrovascular disease, and peripheral arterial disease) are analyzed. This review aims to concisely concentrate all the evidence to facilitate the view on the vascular involvement of the Wnt pathway and its components by highlighting the importance of exploring possible therapeutic strategy for patients with T2DM who develop vascular pathologies. | |
dc.description.sponsorship | This research was funded by Instituto de Salud Carlos III grants (PI18-00803, PI21-01069, and PI18-01235), co-funded by the European Regional Development Fund (FEDER) and by a Junta de Andalucía grant (PI-0268-2019). In addition, R.S.-T. was funded by the University of Granada with co-funding by FEDER, (grant number 8110), and C.G.-F. and S.G.-S. were funded by a postdoctoral fellowship (CD20/00022) and a predoctoral fellowship (FI19/00118), respectively, from the Instituto de Salud Carlos III. | |
dc.description.version | Si | |
dc.identifier.citation | Sanabria-de la Torre R, García-Fontana C, González-Salvatierra S, Andújar-Vera F, Martínez-Heredia L, García-Fontana B, , et al. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus. Int J Mol Sci. 2022 Jun 23;23(13):6995. | |
dc.identifier.doi | 10.3390/ijms23136995 | |
dc.identifier.essn | 1422-0067 | |
dc.identifier.pmc | PMC9266892 | |
dc.identifier.pmid | 35805996 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266892/pdf | |
dc.identifier.unpaywallURL | https://www.mdpi.com/1422-0067/23/13/6995/pdf?version=1656065275 | |
dc.identifier.uri | http://hdl.handle.net/10668/21170 | |
dc.issue.number | 13 | |
dc.journal.title | International journal of molecular sciences | |
dc.journal.titleabbreviation | Int J Mol Sci | |
dc.language.iso | en | |
dc.organization | Hospital Universitario San Cecilio | |
dc.organization | Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) | |
dc.page.number | 20 | |
dc.publisher | MDPI AG | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.relation.projectID | PI18-00803 | |
dc.relation.projectID | PI21-01069 | |
dc.relation.projectID | PI18-01235 | |
dc.relation.projectID | PI-0268-2019 | |
dc.relation.projectID | 8110 | |
dc.relation.publisherversion | https://www.mdpi.com/resolver?pii=ijms23136995 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Wnt pathway | |
dc.subject | cardiovascular disease | |
dc.subject | macrovascular disease | |
dc.subject | microvascular disease | |
dc.subject | type 2 diabetes mellitus | |
dc.subject.decs | Diabetes Mellitus Tipo 2 | |
dc.subject.decs | Enfermedad arterial | |
dc.subject.decs | Periférica | |
dc.subject.decs | Enfermedades cardiovasculares | |
dc.subject.decs | Sistema cardiovascular | |
dc.subject.mesh | Cardiovascular Diseases | |
dc.subject.mesh | Cardiovascular System | |
dc.subject.mesh | Diabetes Complications | |
dc.subject.mesh | Diabetes Mellitus, Type 2 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Peripheral Arterial Disease | |
dc.subject.mesh | Wnt Signaling Pathway | |
dc.title | The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 23 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1